Histamine H<sub>4</sub> receptor antagonism reduces hapten‐induced scratching behaviour but not inflammation
Kristine Roßbach(University of Veterinary Medicine Hannover, Foundation), Wolfgang Bäumer(Freie Universität Berlin), Stephanie Wendorff(University of Veterinary Medicine Hannover, Foundation), Thomas Werfel(Medizinische Hochschule Hannover), Manfred Kietzmann(University of Veterinary Medicine Hannover, Foundation), Ralf Gutzmer(Medizinische Hochschule Hannover), Holger Stark(Goethe University Frankfurt), Kerstin Sander(Goethe University Frankfurt)
Cited by 127
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
|The Lancet Oncology|2021|388
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381